Gender Risk in Rheumatic Disease
Apr 03, 2023
The risk of autoimmunity and rheumatic disease is heightened in women, especially with aging and certain populations
Daily Download
VTE Risks and JAK inhibition
Mar 13, 2023
Comparing ACR21 vs EULAR22 RA Guidelines
Feb 22, 2023
Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines
Oral Surveillance - Issues for Clinic
Jan 31, 2023
SLE - New Drug Development
Jan 06, 2023
GCA and PMR New Drugs
Dec 14, 2022
JAKi Regulatory Decisions - FDA, EMA, Canada
Nov 15, 2022
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
Arthritis Clinical Trials Comparison Grid
Oct 10, 2022
Use this resource to keep track of your clinical trials and key information needed when communicating with patients about a drug study.
COVID Deaths at 3 vs. 30 Months
Sep 13, 2022
Comparison of COVID-19 deaths in the first 3 mos vs. over 30 mos since onset. USA leads the way.
Seven Ways to Diagnose Arthritis - Labs
Sep 05, 2022
An overview of how to use serologic testing - ANA, RF, CCP, ESR, CRP